Investment Q&A

Q: Hi 5i,

Do you know who the inside sellers were with the recent DND financing?

Can you provide information on the new debenture? Interest rate and conversion price would be nice.

Thanks
John

Q: Hello 5I
I am thinking of switching CGI Group (1.05% of portfolio) and OTEX (3.19% of portfolio) for TOPICUS , looking for more growth. TOPICUS also looks like a company that may employ AI going forward in their vertical market software offerings. I am a bit overweight Technology but not concerned about it.
You thoughts please
Thank You
Clarence

Q: Like 5i, I have held Enbridge for quite sometime. Looking back to 2014, Enbridge has gone nowhere and depending on the purchased price, e.g. 5i's case, in the negative. As explained to Paul a week ago Dividend is great, still very safe, etc. Now with the latest weak quarter, all the political, environmental hoopla; could you explain the benefits, even in an income portfolio of why Enbridge should be retained.
Thank You, Stephen S

Q: Good morning. Can I get your thoughts on ADN,,,, Advent Technologies? Thanks.

Q: How does one approach bond investments given the low interest rates. I see XBB had a significant drop today. Why? How would you compare XBB to PMIF?
I am retired senior 78 with a pension.
Thank you

Q: Hi team,

Please provide your opinion on Shopify Q4

Thanks!

Q: Is Topicus not cheaper on a p/s and p/e basis than Constellation? And if my calculations are correct, does it not have more cash flow to buy companies, relative to the market cap of the two? Thanks.

Q: I am uncertain regarding calculating acb when,say, a husband and wife own the same stock in different taxable accounts. Is it required to calculate acb from both husband and wife's account, or from each account individually? Sorry to trouble you with such an elementary question. But, I did a Google search and didn't find anything.

Q: Do you have a recommendation for stocks or etfs that have a palladium play that are on the tax? Thank you.

Q: I currently own ATD.B in my RRSP. I am considering selling ATD.B and replacing with BAM or BIP.UN. I would appreciate your thoughts.

Thank You

Kim

Q: My top holdings are:
GOOG 6.61%
AAPL 5.21%
AMZN 5.12%
NVDA 4.61%
V 4.23%
NPI 3.75%
WSP 3.58%
PBH 3.37%
XBB 3.21%
COST 3.1%
OHI 3.48 %
ENB 2.8%
JPM 2.72%

They make up 50% of my portfolio. I have 12% in cash. Would you add or reduce any of these positions? Long investment horizon(17 years). I’m over weight consumer cyclicals and FS (3% BMO and 3% BNS). Light industrials @7%.

Q: What sector would you put Enphase in: Energy, Utilities, Technology, Industrial or a mixture as it seems to touch all of these? It is obviously tied to Renewables but that is not a sector on its own.

Q: Good Morning 5I Team, Thanks for the all your great advise.
As per the portfolio analysis I need to increase my International allocation which is currently at 10%. The Portfolio analysis classifies my following stocks/ETFs as International Brlxf, EWA, HFPC.U:CA, ATCO, BBU.UN, BPY.UN, BEP.UN, MDT.
Can you please suggest some growth stocks or ETFs to add to above holdings to increase my International allocation as well as if any of the above holdings doesn't have potential and can be reallocated? I am looking at long term over 5 to 10 years and have limits in my TFSA & RRSP account.
Please deduct Credits as deemed appropriate.
Thanks

Q: I was bullish on this for some time because the Ontario Gov't paid them to develop expanded, locally produced lab products, including but not limited to COVID and other testing reagents and VTM.
My fear was that a cheap, rapid test would make their COVID line irrelevant, but variants may be just the thing to keep their more technical tests relevant long-term.
How would you now view their risk/return as I want to add to my small 1% position?

Q: I thought CVS was a reasonably good value at or below its recent price in the mid-70 dollars. It reported results today February 16, and tumbled ~ 5%. Before release of those latest results, I had calculated ROE just under 15% and PEG at ~2.4. (1) Do you have updates to key metrics, in addition to the above-noted ones (incorporating the latest results). (2) CVS’ acquisition of Aetna did cause indigestion, but I thought things were much better now. Not so? (3) I had also thought CVS’ participation in the administration of vaccines would very likely enhance impulse sales also. I am wrong on that too? ( So far, I am scoring zero out of 10, yes?)

Am I wrong about CVS? If it is not worth adding to my position, should I sell or leave my half position in peace for now and just monitor?

Q: This small cap is way up. Do you think it has legs?

Q: Why is this warrant spiking so much?

Q: This is a profitable little vertically integrated marijuana Co. What are your thoughts as a long-term speculation? Can you opine on the recent run-up on above average volume please?
Thx.

Q: I'd really like to see 5iReseach provide members with a table listing ALL company reports with three columns, (company name; most recent rating; and date of report issuance. The current presentation of reports is waste of time to search through page by page, only to find a company of potential interest and find the report out-of-date. We should be able to see at all reports at a glance, perhaps by alphabetical order or rating.
Looking forward to your reply,

Q: In light of TFII's recent acquisitions, would you expect an equity offering to help fund the deals?

Thanks.

John